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1. Introduction 
Incidence of congenital heart disease (CHD) is about 0.8%1 and most of these CHD children 
(80%) survive to adulthood in developed countries due to early diagnosis and intervention 
along with improved surgical and anaesthetic techniques. But the situation is different in 
most of the third world countries, where 90% of these children receive suboptimal or no 
care2. These patients commonly admitted in the hospital for procedures like cardiac 
catheterization, radiological procedures3 4, dental and cardiac surgery.  
There is increased risk of mortality and morbidity5 under anaesthesia as their anaesthetic 
management in the operating room is challenging in several respect. Few heart defects are 
so complex that you need to involve paediatric cardiologist and intensivist for complete 
understanding of anatomy and pathophysiology of heart defect.  
Adult population with congenital heart defects has also increased6 7 over the years and 
poses more challenges for anaesthesiologist in perioperative period. It is now expected that 
soon there will be more adult with congenital heart defects than children. Grown up 
congenital heart (GUCH) is a separate entity, which requires expertise of different 
disciplines to prevent associated morbidity and mortality8 during operations (cardiac or non 
cardiac) particularly in uncorrected defects and in pregnant patients. 
When a cardiac defect is recognized in a paediatric patient then the presence of other cardiac 
and extracardiac lesion is a possibility. The incidence of extra cardiac malformation is as high 
as 20 – 45% and chromosomal abnormalities in these CHD patients is found to be 5-10%.  
Perioperative anaesthetic considerations include preoperative evaluation, management of 
hypoxaemia, shunt, polycythaemia, pulmonary hypertension and ventricular dysfunction. 
2. Classification 
Several classifications of CHD have been introduced. Two are given below 
2.1 Cyanotic/Acyanotic CHD 
2.1.1 Acyanotic 
a. Ventricular Septal Defect (VSD) 
b. Atrial Septal Defect (ASD) 
c. Patent Ductus Arteriosus (PDA) 
d. Atrio ventricular Septal Defect (AVSD) 
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e. Pulmonary Stenosis (PS) 
f. Aortic Stenosis (AS) 
g. Coarctation of the Aorta 
2.1.2 Cyanotic CHD 
a. Tetralogy of Fallot 
b. Transposition of the Great Arteries (TGA) 
c. Total Anomalous Pulmonary Venous Return(TAPVR) 
d. Tricuspid Atresia  
e. Truncus Arteriosus  
f. Uncommon, each <1% of CHD, pulmonary atresia, Ebstein’s anomaly. 
2.2 Classification on the basis of pulmonary and systemic flow 
1. Excessive Pulmonary Blood Flow 
a. VSD, ASD, PDA, PAPVR 
2. Inadequate Pulmonary Blood Flow 
a. Tetralogy of Fallot, Pulmonary atresia  
3. Inadequate or obstruction to systemic blood  flow 
a. Coarctation of Aorta 
4. Abnormal Mixing 
a. TGA 
3. Preoperative consideration 
Three type of paediatric CHD patients are expected to come for evaluation. 
1. Patients with uncorrected cardiac defect 
2. Patients who had previous palliative surgery 
a. ToF with BT shunt 
b. Atrial septostomy for TGA 
3. Patients in whom total correction has been done but they may have residual defects 
requiring certain procedures9 
Preoperative evaluation should include detailed information about cardiac lesion, altered 
physiology and its implications. There are few questions which should be clearly answered 
during preoperative evaluation of these CHD patients. These includes 
a. Complete understanding of the anatomical changes due to cardiac defect or palliative 
procedure 
b. Direction and amount of shunting 
c. Presence and severity of pulmonary hypertension 
d. To what extent pulmonary flow reduced or increased? 
e. Degree of hypoxaemia, Polycythaemia  
f. Coagulation abnormalities 
g. What associated pathophysiological findings likely will influence the management? 
h. Functional status of the patient 
Fatigue, headache, visual disturbances, depressed mentation and paraesthesia of toes and 
fingers are presenting symptoms of polycythaemia. History of cyanosis and congestive heart 
failure (CHF) are major manifestations of CHD. Fatigue and dyspnoea on feeding and 
irritability indicate poor functional status. Cyanosis occurs due to decrease pulmonary flow 
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anatomically or functionally (Mixing lesion). Cyanosis may be permanent or appear 
intermittently. Cyanosis may not be seen in new born due to presence of faetal haemoglobin 
which is highly saturated at a given PaO2.  
High pulmonary flow leads to pulmonary edema. Failure to thrive and feeding problems 
are common in patients with history of repeated pulmonary congestion. Patient may 
presents with tachycardia, tachypnoea, irritability, cardiomegaly and hepatomegaly. The 
right ventricular function should also be assessed as it is equally important in paediatric 
CHD patient. 
Try to avoid dehydration in cyanotic CHD patients by allowing clear liquids two hours 
prior to surgery (Table 1). Children also have low glycogen stores which makes them 
vulnerable to hypoglycemia. If timing of surgery uncertain then start an intravenous line 
and give glucose containing solution. Midazolam10 11 is a preferred sedative in the doses of 
0.5 to 1mg/kg or even higher doses in few studies given orally half hour before surgery 
(Table 2). If patient is on prostaglandin (PGE1) infusion then it should be continued. 
 
2hrs Clear liquids (water, apple juice, pedialyte) 
4hrs Breast milk 
6hrs Formula & Cow milk 
6hrs Solids 
Table 1. NPO Orders 
 
Age Premedication 
< 6 months None 
6 months to 8 years Midazolam  
Oral 0.5- 1.0mg/kg (Max. 12 mg) 
Intravenously 0.05 – 0.2mg/kg 
Chloral hydrate 40 – 50mg/kg 
> 8 years Midazolam 7.5 mg PO 
Morphine 0.1mg/kg IM 
Ketamine 4mg/kg IM 
Table 2. Premedication orders 
4. Investigation 
Polycythaemia is very common which increases blood viscosity and leads to thrombosis and 
infarction in cerebral, renal and pulmonary region. Although polycythaemia leads to 
intravascular volume expansion but at the same time reduces plasma volume. Coagulation 
abnormalities also occur due to hypofibrinogenaemia and factor deficiencies. Platelet count, 
PT and PTT should be ordered in all patients coming for surgery. Preoperative phlebotomy 
can be performed in patients with symptomatic hyperviscosity and haematicrit > 65%.  
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Electrolyte abnormalities are commonly seen in patients who receive diuretics and parental 
nutrition. Hypocalcaemia commonly found in patients with Di George syndrome.  
ECG may show ventricular strain or hypertrophy pattern. Echocardiography is used for 
doppler and color flow mapping while catheterization is used for information about 
pressures in different chambers, magnitude of shunt and coronary anatomy. Examine chest 
X-Ray for heart position (Dextrocardia) and size, atelectasis, acute respiratory infection, 
vascular markings and elevated hemidiaphragm. High pulmonary flow will leads to 
increased pulmonary marking while reduced flow causes oligaemic lung fields. 
Neurological assessment and MRI12 may also be needed in these patients. Delayed brain 
development is associated with certain CHD. Fetal MRI can help in early assessment of 
immature brain.  
5. Intraoperative considerations 
Presence of CHD in paediatric patients poses a great challenge for anaesthetist13 as 
morbidity and mortality is quite high. Incidence of cardiac arrest in these paediatric patients 
under anaesthesia is higher14 than non CHD patients and mainly due to pharmacological 
interaction and over dose5.  
Intravenous line must be placed in all patients even for minor procedure. All intravenous 
tubings should be free of air bubble. Polycythaemic patient must be well hydrated before 
induction either by IV or orally. 
Sevoflurane15 is preferred over halothane due to better haemodynamic stability in CHD 
patients. Most of the CHD patients tolerate inhalation induction with sevoflurane while 
patients with poor cardiac function, may not tolerate inhalation induction. Ionotropes 
should be continued if patient is on ionotropes.  
5.1 Monitoring 
Monitoring in paediatric CHD is the same as in adult cardiac surgery but there are few 
differences and considerations during surgery. Monitoring during surgery ranges from 
simple ECG to blood glucose, which is controversial due to non availability of evidence that 
tight blood sugar control improves outcome16. 
5.1.1 Electrocardiogram 
Although ECG can be helpful in the detection of ST changes but is mainly used for 
arrhythmia detection in paediatric patients. Even arrhythmia detection is difficult due to 
baseline tachycardia. Skin should be prepared for electrode by rubbing with alcohol pad or 
swab. Three leads system is commonly used while in older children five leads system can 
also be used. 
5.1.2 Blood pressure monitoring 
Non invasive monitoring 
Non invasive blood pressure should always be monitored even in the presence of arterial 
line. Cuff should be 20% wider than the diameter of limb where non invasive blood pressure 
is monitored. Smaller cuff results in erroneously high pressure while larger cuff will give 
lower pressures.  
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Invasive pressure monitoring 
It not only provides beat to beat continuous blood pressure monitoring but also provides 
easy access for blood sampling. Pressure monitoring tubing and stopcocks should be free of 
air to prevent air embolism and damping of system. It is also a major source of fluid 
overload as system continuously flushes 2-4 ml/hr per invasive line. In addition a quick 
flush also pushes about 1-2 ml of fluid per second . Dextrose can be used but usually normal 
saline is the flushing solution as bacterial growth is less likely. 
5.1.3 Central venous pressure 
Central venous access not only helpful in monitoring but also provides a reliable route for 
drugs, fluid and blood. Right internal jugular vein (Table 3) is commonly used due to its 
straight course to right atrium while left side is avoided due to concerns about its persistent 
connection to left SVC (which may be ligated during surgery). Alternatively femoral and 
subclavian veins can also be used. 
 
Weight CVP 
< 5kg or less than one year 4F, 5cm 
5 – 20 kg 4F, 8cm 
>20 kg 5F, 8 or 13cm 
Adult 7F 
Table 3. Central venous catheter (Internal Jugular Vein) size according to weight 
5.1.4 Pulse oximeters 
Usually two oximeters are placed , one in the upper limb and other in the lower extremity. 
Pulse oximeter uses two light emitting diodes and one photodiode for detection of red and 
infra red lights.  




4. Artifacts due to 
a. Thick skin 
b. Dark color 
c. Bright outside light 
d. Presence of dyes like indocyanine green and methylene blue 
5. Abnormal haemoglobins 
a. Met Hb 
b. Carboxy Hb 
Not affected by fetal hemoglobin. 
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5.1.5 Cerebral oximeter 
Transcranial near-infrared spectroscopy (NIRS)17 is a sensitive measure of regional 
hypoperfusion. It measures all haemogloblins and useful in non pulsatile cardiopulmonary 
bypass and circulatory arrest. Cerebral oximeter detects intravascular haemoglobin oxygen 
saturation of cerebral cortex. 
5.1.6 Echocardiography 
Intraoperative transesophageal echocardiography (TEE) plays a critical role in improving 
surgical outcome in CHD surgeries by confirming diagnosis and identifying residual 
defects. It is also helpful in the placement of devices in catheterization lab. 
Micromultiplane TEE probe and three dimensional technologies are new advances in 
echocardiography. Epicardial echocardiography is an alternative option in institutions 
where smaller TEE probe is not available18. Adult TEE probe can be used in patient 
weighing more than 20Kg. 
Arterial blood gases and blood glucose should also be done frequently. Tight blood glucose 
control is suggested by certain authors as high blood sugar is toxic to mitochondria.  
Intraoperative management  
Anaesthetic management during surgery depends on presence or absence of shunt, 
pulmonary hypertension, hypoxaemia, Ventricular dysfunction, pulmonary flow and 
arrhythmia. 
5.2 Shunt 
Shunting through these defects depends upon diameter of defect and balance between 
systemic and vascular resistance. Balance between systemic vascular resistance (SVR) and 
pulmonary vascular resistance (PVR) is essential in the anaesthetic management of patient 
with shunts. 
Normal pulmonary: Systemic ratio (Qp:Qs ratio) is 1:1 which indicate either no shunting or 
bidirectional shunt of equal magnitude. Qp:Qs ratio of 2:1 indicate left to right shunt while 
less than 1:1 ratio (0.8:1) means right to left shunt. The ratio is estimated from oxygen 
saturation measurements at pulmonary veins, pulmonary artery, systemic arterial and 
mixed venous blood. 
5.2.1 Left to right shunt  
1. Atrial septal defect (ASD) 
2. Ventricular septal defect (VSD) 
3. patent ductus arteriosus (PDA) 
4. Atrio ventricular (AV) canal defects 
5. Complete anamolous venous return (CAVR) 
6. Partial anomalous venous return (PAVR) 
7. Artificial Blalock taussig (BT shunt)  
L –R shunt reduces greatly with drop in SVR or an increase in PVR. It leads to excess 
pulmonary blood flow. Patients are usually acynotic but deterioration in gas exchange may 
result from pulmonary congestion. Avoid 100% oxygen and hyperventilation in patients 
with L  R shunt.  
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Patients with PDA are vulnerable to coronary ischaemia11 due to ongoing pulmonary 
runoff during the diastolic phase. Therefore diastolic blood pressure (DBP) should be 
monitored during surgery. Diameter of Modified Blalock Taussig shunt is fixed so its 
output is proportional to SVR and in case of systemic hypotension, the pulmonary blood 
flow will be reduced. Blood pressure in the arm will be low due to BT shunt, so use 
contralateral limb.  
5.2.2 Right to left  
These intra cardiac shunts lead to prolong inhalation induction. R  L shunt (e.g. tetralogy 
of fallot (TOF) or shunt reversal12 occur when SVR drops or PVR increases. Hypercyanotic 
spell under anaesthesia will respond to volume, Increase SVR with alpha agonists such as 
Phenylephrine. 
5.3 Hypoxaemia 
Inadequate pulmonary blood flow and/or admixture of deoxygenated with oxygenated 
blood in systemic circulation are usually responsible for ischaemia. In addition pulmonary 
congestion with inadequate exchange of gases can also leads to hypoxaemia.  
Persistent hypoxaemia leads to following changes 
a. Slightly  HR 
b. Hyperventilation  
c. Polycythaemia  
d. Chemoreceptor response to hypoxaemia reduced 
e. Cerebral and myocardial oxygenation maintain but Visceral and muscular oxygenation 
reduced 
f. Reduced metabolic activity of many organs 
a. Growth retardation 
g. Myocardial ischaemia can occur 
h. Myocardial dysfunction 
i. Down regulation of β - receptors  
The anaesthetic management includes adequate hydration, maintenance of systemic blood 
pressure, minimizing additional resistance to pulmonary blood flow and avoids sudden 
increase in oxygen demand (crying, struggling, and inadequate level of anaesthesia). 
5.4 Pulmonary hypertension (HTN) 
During early stages, the pulmonary HTN is reactive and responds to hypothermia, stress, 
pain, acidosis, hypercarbia, hypoxia and elevated intrathoracic pressure but later pulmonary 
HTN becomes fixed. This last stage, where pulmonary vascular resistance exceeds SVR and 
symptoms appear due to R  L shunt, is the Eisenmenger syndrome13.  
Anaesthetic risk is quite high including right ventricular failure, bronchospasm, pulmonary 
hypertensive crisis and cardiac arrest. Anaesthetic management focus on preventing further 
increase in R-L shunt by keeping SVR high and PVR low, maintaining myocardial 
contractility and prevention of arrhythmia and hypovolemia. 
5.5 Ventricular dysfunction 
Chronic volume overload (Large shunts, valvular regurgitation), Obstructive conditions and 
cardiac muscle diseases leads to reduced ventricular function. Blood gas and X-Ray may 
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show metabolic acidosis and pulmonary edema respectively. Patients are usually on 
digoxin, diuretics and ionotropes.  
Anaesthetic considerations includes 




d. Antiarrhythmics or ablation in patients with arrhythmia 
2. Preoperative CBC and electrolytes 
3. Etomidate and fentanyl provide cardiovascular stability at the time of induction 
4. Avoid or limit the use of inhalation anaesthetics due to associated myocardial 
depression 
5. Maintain normal sinus rhythm  
6. Maintain preload during anaesthesia.  
7. After load reduction in certain situations 
5.6 Miscellaneous concerns 
5.6.1 Neurological outcome 
There is growing concern about their quality of life and neurocognitive function, as the long 
term survival of these children is now possible. 20 -50% may develop neurological 
impairment due to chronic hypoxaemia, prolong deep hypothermic circulatory arrest and 
prolong exposure to anaesthetics. Non pulsatile low flow during cardiopulmonary bypass 
causing ischaemia/reperfusion injury may also play a part19.  
Brain adapts to chronic hypoxia due to presence of NMDA 2B receptors in early life. Cortical 
neurons may reduce by 30% due to chronic hypoxia causing reduction in brain volume. But 
this reduction is compensated when normoxia develops after surgery. Although most of the 
article have supported the use of high dose narcotics in over all outcome but at present there 
is no concrete evidence about best anaesthetic agents for congenital heart surgery. 
5.6.2 Coagulation disturbances 
Coagulation abnormalities are very common in CHD patients particularly in cyanosed and 
polycythaemic patient.  
Coagulation derangement associated with polycythaemia includes: 
1. Decreased platelet count and function 
2. Primary fibrinolysis 
3. Impaired coagulation factors production 
4. Contracted serum volume 
Use of blood products is common in paediatric cardiac surgery due to coagulopathy during 
surgery and several strategies have been instituted to minimize this practice. Preoperative 
exchange transfusion of 20 ml/kg FFP to replace same amount of blood is an effective 
method to counter coagulopathy. Antifibrinolytics like aprotinin and tranexamic acid20 have 
been used for this purpose. Aprotinin is no longer recommended in cardiac surgery due to 
higher incidence of renal failure, stroke and myocardial infarction while the use of 
tranexamic acid has increased.  
Tranexamic acid as a part of blood saving strategy is given as a bolus of 100mg/kg followed 
by 10 mg/kg/hr infusion. Whole blood transfusion is quite effective in coagulopathic 
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patients. Factor VII in the dose of 90 microgram/kg is increasingly used in paediatric 
congenital heart surgeries. 
5.6.3 Grown up congenital heart (GUCH) 
Pregnancy 
Increased in blood volume during pregnancy may further aggravate the situation and 
patient may develop arrhythmias, pulmonary congestion and heart failure. Consideration 
during pregnancy ranges from termination of pregnancy to the safe delivery by caesarean 
section. A multidisciplinary approach involving obstetrician, paediatric cardiac surgeon, 
paediatric cardiologist, intensivist, anaesthetist and neonatologist is essential in decision 
making process.  
Anaesthetic challenges and considerations include  
1. Invasive line monitoring according to the severity of cardiac defect  
2. Slow infusion of lowest effective dose of oxytocin as vigorous uterine contraction leads 
to high pre load  
3. Use of inline air filter  
4. Reduction in SVR should be avoided 
5. Coagulation abnormalities should also be considered  
6. Prevention of thromboembolic events 
Eisenmenger 
Most of the patients with Eisenmenger started with simple correctable cardiac defects but 
eventually leads to severe pulmonary hypertension (PVR > 800 dynes/cm-5) which does not 
respond to pulmonary vasodilators. Hypoxaemia, myocardial dysfunction and arrhythmia 
is a common finding.  
Perioperative risk includes 
1. Arrhythmia 
2. Cardiac arrest 
3. Pulmonary hypertensive crisis 
4. Bleeding 
5. Thrombosis 
Anaesthetic management includes 
1. Phlebotomy in hyperviscosity syndrome 
2. Avoid dehydration in preoperative period 
1. Avoid myocardial depressants 
2. Keep SVR high 
3. Try to reduce PVR 
4. Regional anaesthesia can be used but general anaesthesia is preferred 
5. Postoperative pain should be adequately managed 
6. Will require intensive care after surgery 
6. Common CHD 
6.1 Ventricular septal defect (VSD) 
VSD is the most common congenital heart defect. It may be an isolated cardiac defect or may 
be associated with other cardiac defects like ASD, PDA or a part of complex defects 
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(tetralogy, AV canal defect). Communication between two ventricles can be of any size and 
can occur at any part of septum. Most common type of VSD is peri membranous (also called 
subaortic or infracristal). Other less common defects are subpulmonary (Supra cristal, 
infundibular or outlet type), Inlet type (canal type) and muscular. Spontaneous closure is 
possible in muscular and membranous type of defects.  
Smaller defects are not associated with large shunting of blood from left ventricle to right 
ventricle may not diagnose early in life but they are prone to infective endocarditis. Whereas 
larger defects cause shunting of blood from left to right ventricle this led to higher 
pulmonary blood flow and consequently pulmonary congestion. Due to early development 
of symptoms these patients diagnosed earlier. During systole LV ejects blood not only in the 
aorta but also in the pulmonary artery causing volume overload of pulmonary vessels, atria 
and left ventricle. These patients will develop high pulmonary vascular resistance (PVR) 
and if untreated will leads to Eisemenger. 
A device like amplatzer can be placed to close few of these defects by interventional 
cardiologist. This procedure is performed in the cath lab as a daycare procedure but there 
are certain criteria needs to be fulfilled. There should be an adequate rim around the defects 
where amplatzer can be placed. Surgically VSD can be approached through ventricle, aorta, 
pulmonary artery or right atrium.  
Anaesthetic considerations 
Always consider high pulmonary vascular resistance in these patients and be ready to treat 
high PVR and right ventricular failure by inhaled NO, dobutamine and milrinone. Desirable 
haemodynamic goals by anaesthetists are to have slightly higher preload and pulmonary 
vascular resistance while keeping the SVR on the lower side and at the same time 
maintaining heart rate and contractility. Up to 10% of patients may develop conduction 
abnormalities after VSD repair which may be transient or permanent.  
Intraoperative transesophageal echocardiography (TEE) will be beneficial in recognizing 
residual defects, intracardiac air and right ventricular function. Smaller VSD are sometimes 
becomes apparent after closure of large defect. In uncomplicated VSD closure patient can be 
extubated in the operating room. 
6.2 Atrial septal defect (ASD) 
Normally there is no communication between right and left atria due to presence of a 
septum. This atrial septum composed of septum primum and septum secundum which 
merges with endocardial cushion, superior and inferior vena cava.  
Several types of defects can occur in this septum leading to shunting across. Apart from 
secundum defect other less common are primum, sinus venosus and coronary sinus type.  
Most common defect is ostium secundum which usually located in the centre (also called 
fossa ovalis type) and occurs due to deficient septum primum. It may be single or have 
several small defects called fenestrated type. Patent foramen ovale commonly seen at the 
same site in 25 – 30% of normal patients. Usually PFO do not permit left to right shunting 
but right to left shunting can occurs if right atrial pressure exceeds left atrial pressure 
(sneezing, valsalva) 
Sinus venosus defect is usually associated with partial anomalous pulmonary venous 
drainage and appears either at the junction of superior vena cava and atrial septum (High 
up) or at the junction of inferior vena cava and septum (located lower part of septum). 
Repair some time may cause injury to SA node. 
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Ostium primum defect is due to failure of fusion between endocardial cushion and lower 
part of interatrial septum leading to communication between two atria and usually 
associated with cleft at anterior mitral leaflet.  
Coronary sinus type defect is due to absence of wall between left atrium and coronary sinus 
leading to communication between left and right atrium. It may be associated with 
persistent left SVC. 
Left to right shunting depends on the size of defects and compliance of ventricles as 
shunting usually occurs during diastole when both mitral and tricuspid valves are open. If 
the defect is small (less than 5 mm) then it’s called restrictive type while larger defects are 
non restrictive and associated with right atrial dilatation, RV volume overload and 
increased pulmonary blood flow. Spontaneous closure is possible but most require device 
closure by cardiologist or surgery. 
Anaesthetic considerations 
Inhalation induction in infants and very young and intra venous induction in older children 
is acceptable technique. Intramuscular ketamine can be alternative for induction or intra 
venous line placement in some children. Pulmonary hypertension is generally not seen in 
these patients and their management is usually simple with the goals of higher preload and 
slightly high PVR to reduce pulmonary flow. Presence of ASD is not usually poses higher 
risk for infective endocarditis.  
TEE is helpful to see the residual ASD, mitral valve repair (primum type), four pulmonary 
veins opening in left atrium (Sinus venosus type). Tracheal extubation in the operating room 
will help in minimizing the charges. 
6.3 Tetralogy of Fallot (ToF) 
ToF is the most common cyanotic CHD, accounting for 10% of all CHD. It comprises of four 
anatomical defects: (i) VSD (ii) RVOT obstruction (iii) RV hypertrophy (iv) Over riding of 
aorta.  
VSD is usually large, non restrictive which led to equalization of RV and LV pressures and 
shunting through VSD depends primarily on systemic and pulmonary vascular resistance. 
RVOT obstruction is dynamic due to hypertrophied infundibulum but fixed obstruction can 
also occur due to v pulmonary valve stenosis.  
Due to reduce pulmonary flow, main and branched pulmonary arteries hypoplasia may also 
be seen. Right ventricular hypertrophy is more marked when VSD is restrictive. ToF may 
also be associated with certain defects like anomalous origin of LAD crossing the RVOT, 
pulmonary atresia, absent pulmonary valve and complete AV canal defect. 
Palliative surgery 
The classic Blalock Taussig shunt was performed in 1944 to relieve the ToF related cyanosis 
where end to side anastomosis of subclavian artery to pulmonary artery was performed. 
Today modified BT shunt is the most commonly performed palliative procedure in CHD 
patients where a synthetic graft is interpositioned between subclavian artery and ipsilateral 
pulmonary artery. 
Complete surgical repair 
First total correction was performed by Lillehei in 1954. Surgical correction involves 
infundibular muscle resection through right ventriculotomy or transpulmonarry approach. 
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Pulmonary valve is removed or dilated accordingly and a transannular patch is placed. VSD 
is also closed at the same setting. Main Pulmonary artery and its branches are also inspected 
for narrowing. Some centres creates small ASD to counteract high right sided pressures. 
There is trend towards early total correction rather than palliative surgery which is followed 
by total correction. 
Anaesthetic management 
Goal of anaesthetic management is to avoid low SVR and ionotropes before bypass. If 
patient is on prostaglandin E1 then it should be continued in pre bypass period. Avoid 
catecholamine release in preoperative phase and at the time of induction by providing good 
premedication and adequate analgesia and anaesthesia.  
Induction can be done with ketamine and fentanyl if intravenous line is in place. Inhalation 
induction can also be performed while maintaining SVR. Remember infundibular stenosis 
increased by increasing contractility and heart rate, so minimize noxious stimulus avoid 
catecholamine release. This is achieved by high dose fentanyl at the maintenance phase. 
Arterial line and central line should be placed after induction and intubation.  
Acute desaturation at any time should be considered as tet spell and treated by analgesics 
and volume. Phenylephrine should also be available to treat low systemic vascular 
resistance and hypotension. Steroids given at the time of induction can help in reducing 
release of inflammatory markers during cardio pulmonary bypass. 
TEE is helpful in assessing residual VSD and infundibular stenosis and degree of pulmonary 
regurgitation. In case of tet spell, give 100% O2, Phenyl ephrine, volume, increase depth of 
anaesthesia, hyperventilate and give bicarbonate. In addition esmolol or proponol can be 
tried to reduce infundibular spasm. 
During postbypass period be ready for arrhythmias and heart block, RV dysfunction and 
coagulopathy. Ionotrpic support is mandatory in postbypass period along with high filling 
pressure particularly if right ventriculotomy was performed. Blood products should be 
available and antifibrinolytics should be started for coagulopathy.  
6.4 Patent ductus arteriosus (PDA) 
Ductus arteriosus is a normal communication in fetus, which constrict and closes within 10-
15 hrs of birth and later closed anatomically by fibrosis in 2 – 3 weeks. Various mechanism 
have been described for initial functional closure, which includes increased PaO2, absence of 
placental derived prostaglandins and presence of catecholamines and bradykinins in new 
born.  
Ductus venosus provides a communication between junction of main and left pulmonary 
artery and lesser curvature of descending aorta after left subclavian artery origin. Higher 
incidence of patent ductus arteriosus is seen in premature, females, children living at high 
altitude and associated with maternal rubella. 
It provides left to right shunt causing high pulmonary flow and volume load on left atrium 
and ventricle. Pulmonary congestion and recurrent infection is commonly seen if remain 
open. 
Medical management includes three doses of indomethacin. If medical management fails 
then either transcatheter or surgical closure becomes necessary. Surgical techniques include 
ligation via left thoracotmyn sternotomy or recently by video assisted thoracoscopy.  
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Anaesthetic considerations 
Anaesthesia management is planned according to prematurity, degree of pulmonary 
congestion and PVR and surgical technique. During surgery aorta, left pulmonary artery 
and left main bronchus can be mistakenly ligated instead of ductus arteriosus. Remember to 
place a pulse oximeter at lower extremity to diagnose ligation of aorta. In addition, DBP will 
rise as soon as PDA is ligated, which will confirm the identification.  
Invasive monitoring is not essential in uncomplicated PDA but arterial line can be placed in 
patients with comorbids to check beat to beat pressure and diagnosis and correction of 
acidosis. Limit Left to right shunt by keeping FiO2 low and PaCO2 between 40–50 mmHg. 
Blood should be available in the room as bleeding is a possibility. 
6.5 Common atrioventricular canal (CAVC) 
It is also called endocardial cushion defect and results from failure of endocardial cushions 
to fuse with lower part of atrial and upper portion of ventricular septum. In addition, 
atrioventricular valves will also be abnormal. There are three different types of CAVC exist. 
1. Partial atrioventricular canal or Ostium primum defect 
a. Usually interatrial communication and cleft mitral valve 
b. Two separate AV valves 
2. Transitional atrioventricular canal defect 
a. Ostium primum plus 
b. Partially separated AV valves 
c. Small to moderate VSD partially closed by chordate attachment 
3. Complete atrioventricular canal defect 
a. Large non restrictive ostium primum 
b. Large VSD 
c. Large common single atrioventricular valve 
Left to right shunting and regurgitation leads to volume loading of both atria and both 
ventricles. Patient will develops pulmonary congestion and pulmonary hypertension. 
Surgery usually performed at the age of 2-5 years and in some cases earlier.  
Anaesthetic management 
Management depends on severity of pulmonary hypertension and degree of left to right 
shunting. FiO2 and ventilation is manipulated along with use of NO and analgesics to 
reduce pulmonary hypertension. Ionotropic support will be required after bypass. TEE will 
be useful in detecting residual defects and ventricular function. LA line along with other 
invasive lines will help in deciding about escalation in ionotropes. 
6.6 Anomalous pulmonary venous connection 
Two types of abnormal communication are seen. Both of these defects may be associated 
with other cardiac lesions like ASD, VSD and PDA. 
1. Partial anomalous pulmonary venous connection  
a. At least one pulmonary vein is connected to right atrium either directly or 
indirectly. Most common is right upper pulmonary vein opening in the superior 
vena cava. These patients may remain asymptomatic for long time. 
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2. Total anomalous pulmonary venous return (TAPVR) 
a. All four pulmonary veins opens in the right atrium. 
b. Four types of TAPVR exist 
i. Supra cardiac 
 Pulmonary veins converge and drains into a vertical vein which then 
drains into right atrium via innominate V or SVC 
ii. Cardiac 
 Common pulmonary confluence drains into coronary sinus 
iii. Infra cardiac or infra diaphragmatic 
 A common confluence of pulmonary vein passes through diaphragm  
and drains in the portal system which then drains into inferior vena  
cava.  
iv. Mixed 
 Pulmonary veins drains at two or more levels. 
Pathophysiology of TAPVR depends on obstructed or non obstructed pulmonary venous 
return. Obstruction will leads to pulmonary venous hypertension and higher back 
pressures. 
Anaesthetic considerations 
PAPVR is associated with higher pulmonary blood flow, so main aim would be to reduce 
pulmonary blood flow. Patients with obstructed TAPVR are sicker and will need higher 
PaO2, ionotropic support and repeated blood gases to control acidosis. Post bypass period 
require high PaO2, hyperventilation, ionotropic support, good sedation, paralysis and 
NO. Intraoperative TEE is usually not done to avoid further obstruction of pulmonary 
veins but TTE and epicardial echo can be performed to look at venous return in the left 
atrium.  
6.7 Transposition of the great vessels 
Transposition is a common CHD which is associated with high mortality without 
intervention. Atrial septostomy is usually performed in the catheterization laboratory to 
stabilize the patient before surgery. PgE1 should be continued before bypass to keep the 
duct opens. Coronary artery21 should be preoperatively assessed as abnormal location of 
coronaries creates surgical difficulties. 
Anaesthetic considerations 
Anaesthetic goal is to avoid reduction in cardiac output and systemic vascular resistance 
while keeping the PVR lower relative to SVR. Increased pulmonary blood flow due to 
reduced PVR will leads to increased mixing of blood and better saturation. Pulmonary 
resistance can be reduced by following measures: 
1. Inhaled nitric oxide (NO) 
2. Nebulized PGI2 
3. Sildenafil (Oral and preferably intravenous) 
4. Ventilatory interventions 
a. Increased FiO2 
b. Reduced carbon dioxide 
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c. Alkalotic PH 
5. At the same time avoid hypoxia, hypercarbia, acidosis, hypothermia, high and low tidal 
volume, high PEEP and hypoglycaemia in neonates. 
7. Postoperative pain management 
High dose opioids are given during paediatric congenital heart surgery and analgesic effect 
continues in postoperative period. Good intraoperative and postoperative analgesia is 
associated with improved surgical outcome22. Morphine in the doses of 25 
microgram/kg/hr will provide adequate analgesia and moderate sedation during 
postoperative period while additional sedatives are needed in intubated patients. Larger 
doses are needed in infants and young children basically due to high clearance.  
Fentanyl at the doses of 1-5 microgram/kg/hr can be given instead to provide continuous 
analgesia but associated with less sedation then morphine. Non opioid analgesics like 
acetaminophen and ketamine can also be used as an adjunct to opioid analgesia. Ketamine is 
given intravenously as a bolus or in the form of continuous infusion at the rate of 10 – 45 
microgram/kg/min. 
8. Anaesthesia for catheterization laboratory procedures 
Diagnostic and interventional cardiology plays a major in the management of congenital 
heart patients. General anaesthesia for these procedures is associated with low risk of 
morbidity and mortality23. Some of the challenges faced by anaesthesiologist in cath lab 
include 
1. Usually located far away from operating rooms 
2. Not equipped with recovery room 
3. Transfer of critically ill patient from intensive care to cath lab or vice versa can create 
several problems 
4. Rooms are usually undersized 
5. Not properly illuminated 
6. Access to patients airway is difficult 
7. Monitoring interference with cath lab equipment 
8. Contrast material use and its complications like contrast induced nephrotoxicity and 
vasovagal reaction 
9. Radiation exposure 
a. Always use shielding devices like gown, glasses and thyroid collar 
b. Keep a distance from radiation source 
c. Minimize exposure time 
d. Different resident and consultant should rotate rather than assigning one person 
for cath procedures 
Catheterization procedures should only be performed in centers where facilities for 
paediatric heart surgery are available. Catheterization procedures can be performed under 
local, monitored anaesthesia care (MAC) and general anaesthesia. There are several 
difficulties which make these procedures lengthy and complicated. Difficulties during 
procedure vary from intravenous access by anaesthesiologist to arterial and venous access 
by cardiologist. Necessary equipment for intubation and drugs for resuscitation should be 
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available as cardiac arrest in these patients is not uncommon24 when sedation is given for 
the procedure.  
Although cardiologists do give sedation for certain procedures but another person  
with ability to resuscitate the patient should be available in cath lab. Laryngeal mask  
airway (LMA) is well tolerated by most of the patients but those patients who can develop 
airway obstruction (Down’s syndrome) during procedure should be intubated before  
the start of procedure. Intubation should also be done on those patients who need  
TEE. Anaesthesiologist has to be very careful during TEE manipulation. High doses  
of analgesia are not required and only local anaesthesia infiltration at access site is  
sufficient. 
9. Complications 
Expected complications during the procedure include 
1. Arrhythmias 
a. Mechanical reasons, electrolyte disturbance and hypercarbia 
2. Brachial plexus neuropathy due to stretching of nerve plexus during positioning 
3. Hypothermia 
4. Vascular damage at access site 
5. Bleeding 
6. Congestive heart failure 
7. Tamponade 
Use of ionotropes and vasopressors should be intentionally reduced, when anaesthesia is 
given for electrophysiological studies to minimize arrhythmias. 
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